Disclosures for "Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility"
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Alper Bulbul has nothing to disclose.
-
Prof. Sezerman has nothing to disclose.
-
Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
-
Umut Voyvoda has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Tuncer has nothing to disclose.
-
Dr. karaman has nothing to disclose.
-
Author has nothing to disclose
-
Caner Feyzi Demirkaya has nothing to disclose.
-
Dr. Boz has nothing to disclose.
-
Cihat Uzunkopru has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
-
Mehmet Fatih Yetkin has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Kurtuncu has nothing to disclose.
-
Dr. Terzi has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Turan has nothing to disclose.
-
Author has nothing to disclose
-
Dr. Karabudak has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Demir has nothing to disclose.
-
Dr. Duman has nothing to disclose.
-
Dr. Gunduz has nothing to disclose.
-
Author has nothing to disclose
-
Author has nothing to disclose
-
Dr. Bilguvar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Advisors. The institution of Dr. Bilguvar has received research support from NIH. The institution of Dr. Bilguvar has received research support from TUBITAK. Dr. Bilguvar has received intellectual property interests from a discovery or technology relating to health care. Dr. Bilguvar has received publishing royalties from a publication relating to health care. Dr. Bilguvar has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
-
Bade Gulec has nothing to disclose.
-
Dr. Tutuncu has nothing to disclose.
-
Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey.
-
Sabahattin Saip has nothing to disclose.
-
Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
-
The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission .